Media

Aiding Cancer Prevention and Treatment by Renaming the BRCA1, BRCA2, and BRCA3 Mutations - Colin Pritchard

Details
Colin Pritchard from the University of Washington joins Charles Ryan at the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019) to speak about his recent editorial that was published in Nature that advocates for a renaming of the genetic syndrome that we commonly call BRCA2 mutation or the "breast cancer gene". They're named the breast cancer genes but it is limiting because prost...

A Prostate Cancer Patient Journey - Joseph Samulenas

Details
(Length of Interview: 3 min) Joseph Samulenas, a prostate cancer patient shares his journey through diagnoses, treatment decisions, and advice he would give himself as a newly diagnosed prostate cancer patient if he had the knowledge he has now. 1. How did you go about making your treatment decision? 2. Did you feel that you had an adequate understanding of all the pro and cons of each treatment t...

A Prostate Cancer Patient Journey - Mark McLain

Details
(Length of Interview: 3 min) Mark McLain, a prostate cancer patient has been battling prostate cancer for the last five years. He shares his journey through diagnoses, treatment decisions, the resources he found useful and the importance of educating yourself as a prostate cancer patient. In this intimate interview, he shares how helpful it was for him to share his story with other men with the sa...

The Changing Landscape for Locally Advanced Prostate Cancer- Maria de Santis

Details
Maria de Santis and Chuck Ryan share a conversation on the rapidly changing landscape for the treatment of locally advanced prostate cancer. A focus of the discussion centers around the STAMPEDE data demonstrating benefit with the early use of abiraterone and the use of radiation. They also discuss the role of docetaxel in this evolving environment based on data from both STAMPEDE and CHAARTED dat...

Disparities and Outcomes in Men with Prostate Cancer - Susan Halabi, Mindy Hebert-DeRouen, and Daniel George

Details
At the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019), Charles Ryan is joined by three physicians to discuss disparities and outcomes in men with prostate cancer. Drs. Susan Halabi, Mindy DeRouen, and Dan George shared highlights from their presentations from the PCF Scientific Retreat. Dr. Hebert-DeRouen shares details on the Disparities Research: Environment and multi oMics...

Epidemiologic Outcomes of Prostate Cancer Patients Undergoing Active Surveillance - Sigrid Carlsson

Details
Sigrid Carlsson joins Charles Ryan discussing the epidemiologic outcomes of men in the current era who are facing active surveillance. She reviews the long term data learned from the Memorial Sloan Kettering Cancer Center Experience which mirrors prior reports with low rates of metastasis or cancer-related deaths for patients on active surveillance. They also discuss the migration of pushing the e...

The Journey of an Aspirational Leader - Lynn Seely

Details
President and CEO of Myovant Sciences, Lynn Seely, MD joins Alicia Morgans, MD and shares highlights of her career journey also presented in her keynote during the 4th Annual PCF Women in Science Forum at the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019). Dr. Seely shares elements from her career journey including her internship and residency in internal medicine at Yale, he...

New Therapeutic Targets for Metastatic Castration-Resistant Prostate Cancer - Aaron LeBeau

Details
At the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019), Charles Ryan is joined by his colleague Aaron Le Beau from the University of Minnesota who specializes in the developments of targeted imaging agents and therapeutics for prostate cancer using novel antibody constructs. Drs. Ryan and LeBeau discuss the work he is doing on potential alternate targets to PSMA. Antibodies we...

The IRONMAN - An International Registry for Men with Advanced Prostate Cancer - Dana Rathkopf

Details
At the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019) Dana Rathkopf and Alicia Morgans discuss the IRONMAN registry. Dana, a strong contributor to the IRONMAN registry trial, explains the goals of the registry and why it is so important for the personalization of patient care around the world. The IRONMAN registry is a population-based observational study currently in nine co...

The Current State of Cell-free DNA in Prostate Cancer - Alexander Wyatt

Details
Alexander Wyatt from the University of British Columbia joins Charles Ryan at the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019) to talk about the current state of cell-free DNA and what a clinician can use in the treatment of prostate cancer from cell-free DNA for current testing. Biographies: Alexander Wyatt, Ph.D., BSc, Assistant Professor, Department of Urologic Sciences,...